Clinical Trial Update: Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma [Phase 1]

View source ↗

Summary

Georgetown University reported Phase 1 results for a trial of Eryaspase in combination with a modified FOLFIRINOX regimen in locally advanced or metastatic panc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Eryaspase (pegylated asparaginase)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Georgetown University | Conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: COMPLETED | Results posted: 2025-02-14